Sushil Kumar Maurya
About Sushil Kumar Maurya
Data last updated:
Sushil Kumar Maurya is a Director at Suvi Pharma Private Limited (since 2016) and Designated Partner at Ayucta Laboratories Llp (since 2021). The companies operate in Service and Chemicals. The largest current company by reported revenue is Suvi Pharma Private Limited at ₹31.1 Lakh (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Suvi Pharma Private Limited U93000MH2016PTC287224 | Director | 28 Oct 2016 | 2016 | ₹31.1 Lakh (FY 2024) | Active |
| Ayucta Laboratories Llp AAX-6423 | Designated Partner | 05 Jul 2021 | 2021 | Active |
Board colleagues of Sushil Kumar Maurya
| Name | DIN | Company | Designation |
|---|---|---|---|
| Rekha Sushil Maurya | 07634720 | Suvi Pharma Private Limited , Ayucta Laboratories Llp | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sushil Kumar Maurya
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sushil Kumar Maurya
Sushil Kumar Maurya currently holds 2 directorships: Suvi Pharma Private Limited (Director, since 28 Oct 2016, revenue ₹31.1 Lakh (FY 2024)); Ayucta Laboratories Llp (Designated Partner, since 05 Jul 2021).
Sushil Kumar Maurya was first appointed on 28 Oct 2016 as Director at Suvi Pharma Private Limited. The most recent appointment on record is 05 Jul 2021 at Ayucta Laboratories Llp.
The current boards of Sushil Kumar Maurya's companies include Rekha Sushil Maurya (Suvi Pharma Private Limited).